What was the effective price per share in the Cosmos Health (COSM) CFO’s exchange?

The effective price was $0.2498 per share, described as the fair market value of Cosmos Health common stock on June 16, 2026. At this rate, $42,000 of debt was exchanged for 168,135 shares classified as Exchange Shares.

Cosmos Health (COSM) CFO swaps $42K company debt for 168,135 shares

Filing Impact

(Neutral)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Terzis Georgios reported open-market purchase transactions in this Form 4 filing.

Cosmos Health Inc. Chief Financial Officer Georgios Terzis acquired 168,135 shares of common stock at $0.2498 per share through a debt-for-equity exchange. Under a Debt Exchange Agreement dated June 16, 2026, $42,000 of debt the company owed to him was converted into these shares.

Following this transaction, Terzis directly holds 2,235,398 Cosmos Health common shares. The transaction reflects an insider increasing his equity stake while eliminating a portion of the company’s outstanding debt obligation to him at the fair market value as of June 16, 2026.

Insider Trade Summary

Net Buyer: 168,135 shares ($42,000)

Net Buy 1 txn

Insider Terzis Georgios

Role Chief Financial Officer

Bought 168,135 shs ($42K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001	168,135	$0.2498	$42K

Holdings After Transaction: Common Stock, par value $.001 — 2,235,398 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares acquired: 168,135 shares Exchange price: $0.2498 per share Debt cancelled: $42,000 +1 more

4 metrics

Shares acquired 168,135 shares Debt-for-equity exchange to CFO

Exchange price $0.2498 per share Fair market value on June 16, 2026

Debt cancelled $42,000 Company debt owed to CFO exchanged for shares

Post-transaction holdings 2,235,398 shares CFO direct ownership after exchange

Key Terms

Debt Exchange Agreement, Exchange Shares, fair market value, Common Stock, par value $.001

4 terms

Debt Exchange Agreement financial

"Pursuant to a debt exchange agreement by and between Georgios Terzis, the Company's CFO and the Company (the "Debt Exchange Agreement"), dated as of June 16, 2026"

Exchange Shares financial

"these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Terzis"

fair market value financial

"at the Exchange Rate ... of $0.2498 per share, the fair market value of the Common Stock on June 16, 2026"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

Common Stock, par value $.001 financial

"security_title": "Common Stock, par value $.001""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/17/2026 - 09:15 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Terzis Georgios

(Last)

(First)

(Middle)

5 AG. GEORGIOU STR.

(Street)

PILEA

THESSALONIKI

TK57001

(City)

(State)

(Zip)

GREECE

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $.001	06/16/2026	06/16/2026	P⁽²⁾		168,135	A	$0.2498	2,235,398	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

2. Pursuant to a debt exchange agreement by and between Georgios Terzis, the Company's CFO and the Company (the "Debt Exchange Agreement"), dated as of June 16, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Terzis at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.2498 per share, the fair market value of the Common Stock on June 16, 2026, in exchange for a total amount of $42,000 in debt the Company owed to Mr. Terzis.

	/s/ Georgios Terzis	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Cosmos Health (COSM) disclose about its CFO in this Form 4?

Cosmos Health reported that CFO Georgios Terzis acquired 168,135 common shares. The shares were obtained via a debt-for-equity exchange, where $42,000 of company debt owed to him was converted at $0.2498 per share, increasing his direct ownership stake.

How many Cosmos Health (COSM) shares does the CFO now own after the transaction?

After the transaction, CFO Georgios Terzis directly owns 2,235,398 Cosmos Health common shares. This reflects the addition of 168,135 shares received under the Debt Exchange Agreement in exchange for cancelling $42,000 of company debt owed to him.

Was cash paid in the Cosmos Health (COSM) CFO’s Form 4 transaction?

No cash changed hands in this transaction. Instead, $42,000 of debt that Cosmos Health owed to CFO Georgios Terzis was converted into 168,135 common shares at $0.2498 per share under a Debt Exchange Agreement dated June 16, 2026.

What is the Debt Exchange Agreement mentioned in the Cosmos Health (COSM) filing?

The Debt Exchange Agreement is an arrangement between Cosmos Health and CFO Georgios Terzis dated June 16, 2026. It provides for issuing Exchange Shares at $0.2498 per share, cancelling $42,000 of debt owed by the company to Terzis in return.